BIORG

Organoids are only the beginning. Biorg is working towards the next generation of preclinical testing with integrative organoid technologies that reduce species comparison errors and enable testing across a broader range of human cell types. Body-on-a-chip. Personalized medicine. Biorg is bringing these advancements with an eye for the power of these discoveries to prevent and reverse disease progression for millions of people... At Biorg, we're transforming how therapies are developed and used. The current methods of drug discovery and treatment are outdated. It takes years and enormous investment to develop a drug. Yet those years of work routinely fail to predict outcomes in humans. Each year, the pharmaceutical industry spends over $171 billion on research to test new drugs, including $52 billion on pre-clinical studies - but over 99% of drug candidates fail. A single failed drug could cost more than $1 billion. What's more, even after a drug is approved, we don't know if or how..

Primary location: Winston-salem United States